Trends in Posterior Cervical Fusion for Deformity in the United States from 2000 to 2017

M. Safaee, C. D. Ore, K. Corso, J. Ruppenkamp, Darryl Lau, C. Ames
{"title":"Trends in Posterior Cervical Fusion for Deformity in the United States from 2000 to 2017","authors":"M. Safaee, C. D. Ore, K. Corso, J. Ruppenkamp, Darryl Lau, C. Ames","doi":"10.1093/neuopn/okaa001","DOIUrl":null,"url":null,"abstract":"\n \n \n Posterior cervical decompression and fusion (PCF) is a common treatment for cervical spondylotic myelopathy. Treatment paradigms are shifting from simple decompression and fusion to correcting cervical deformities.\n \n \n \n To identify trends in PCF with an emphasis on cervical deformity and surgical complexity.\n \n \n \n Adults who underwent PCF from 2000 to 2017 were retrospectively identified in the Premier Healthcare Database (PHD) using International Classification of Disease Codes (ICD) 9 and 10. Patients were dichotomized into those with or without deformity diagnosis. PCF complexity was defined by adjunct surgical codes, including anterior cervical fusion, extension to thoracic levels, and osteotomy. Patient characteristics, including demographics, functional comorbidity index (FCI), and hospital characteristics, were extracted and annual procedures were projected to the US population.\n \n \n \n A total of 68 415 discharges for PCF were identified. Compound annual growth rate (CAGR) of PCF from 2000 to 2017 for nondeformity cases was 9.7% and 16.5% for deformity. The demographics with the greatest growth were deformity patients aged 65 to 74 yr (15.1%). The CAGR of anterior cervical fusion and extension to thoracic levels was higher for deformity patients compared to nondeformity patients, 13.6% versus 3.9% and 20.4% versus 16.6%, respectively.\n \n \n \n Rates of PCF for deformity are increasing at a greater rate than nondeformity PCF. The most growth was seen among deformity patients aged 65 to 74 yr. Surgical complexity is also changing with increasing use of anterior cervical fusion and extension of PCF to include thoracic levels.\n","PeriodicalId":93342,"journal":{"name":"Neurosurgery open","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/neuopn/okaa001","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgery open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/neuopn/okaa001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Posterior cervical decompression and fusion (PCF) is a common treatment for cervical spondylotic myelopathy. Treatment paradigms are shifting from simple decompression and fusion to correcting cervical deformities. To identify trends in PCF with an emphasis on cervical deformity and surgical complexity. Adults who underwent PCF from 2000 to 2017 were retrospectively identified in the Premier Healthcare Database (PHD) using International Classification of Disease Codes (ICD) 9 and 10. Patients were dichotomized into those with or without deformity diagnosis. PCF complexity was defined by adjunct surgical codes, including anterior cervical fusion, extension to thoracic levels, and osteotomy. Patient characteristics, including demographics, functional comorbidity index (FCI), and hospital characteristics, were extracted and annual procedures were projected to the US population. A total of 68 415 discharges for PCF were identified. Compound annual growth rate (CAGR) of PCF from 2000 to 2017 for nondeformity cases was 9.7% and 16.5% for deformity. The demographics with the greatest growth were deformity patients aged 65 to 74 yr (15.1%). The CAGR of anterior cervical fusion and extension to thoracic levels was higher for deformity patients compared to nondeformity patients, 13.6% versus 3.9% and 20.4% versus 16.6%, respectively. Rates of PCF for deformity are increasing at a greater rate than nondeformity PCF. The most growth was seen among deformity patients aged 65 to 74 yr. Surgical complexity is also changing with increasing use of anterior cervical fusion and extension of PCF to include thoracic levels.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2000年至2017年美国颈椎后路融合术治疗畸形的趋势
后路颈椎减压融合术(PCF)是治疗脊髓型颈椎病的常用方法。治疗模式正从简单的减压融合转向矫正颈椎畸形。以颈椎畸形和手术复杂性为重点,确定PCF的发展趋势。使用国际疾病分类代码(ICD) 9和10在Premier Healthcare Database (PHD)中回顾性确定2000年至2017年接受PCF的成年人。患者被分为有或没有畸形诊断。PCF复杂性由辅助手术规范定义,包括颈椎前路融合术、胸段延伸术和截骨术。提取患者特征,包括人口统计学特征、功能合并症指数(FCI)和医院特征,并对美国人群进行年度程序预测。共确定了68 415例PCF出院病例。2000年至2017年,非畸形病例PCF的复合年增长率(CAGR)为9.7%,畸形病例为16.5%。人口统计学上增长最大的是65 - 74岁的畸形患者(15.1%)。与非畸形患者相比,畸形患者颈椎前路融合和胸段延伸的CAGR更高,分别为13.6%对3.9%和20.4%对16.6%。畸形PCF的发病率比非畸形PCF的发病率增长更快。在65 - 74岁的畸形患者中,增加最多。随着颈椎前路融合和PCF延伸至胸椎水平的增加,手术复杂性也在发生变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Spinal Venous Vascular Ectasia With Unusual presentation of Abdominal Pain: Case Report Subsuperficial Pectoralis Fascial Placement of Implantable Pulse Generators in Deep Brain Stimulation Surgery: Technical Note Awake Surgery for a Patient With Glioblastoma and Severe Aphasia: Case Report Changes in Distributed Motor Network Connectivity Correlates With Functional Outcome After Surgical Resection of Brain Tumors Successful Treatment of Pure Aqueductal Pilomyxoid Astrocytoma and Arrested Hydrocephalus With Endoscopic Tumor Resection Followed by Chemotherapy: A Case Report and Technical Considerations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1